Finally, given that sensitivity and specificity are lower for ALT than for MRI [15], and that prevalence estimates were similar for USS and MRI, our results tentatively suggest that ALT may underestimate NAFLD prevalence in young obese people, and overestimate prevalence in the general population. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.